Connect with us

Business

Starpharma (ASX:SPL) share price rebounds after receiving Indian approval for COVID-19 product

Published

on

Image source: Getty Images

The Starpharma Holdings Limited (ASX: SPL) share price has bounced back from weakness this morning and is pushing higher late on Friday.

In afternoon trade, the biotechnology company’s shares are up 1% to $1.69.

This latest gain means the Starpharma…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending